Transient left ventricular clot in COVID-19-related myocarditis is associated with hypereosinophilic syndrome: a case report.
Int J Cardiovasc Imaging
; 37(11): 3279-3283, 2021 Nov.
Article
in English
| MEDLINE | ID: covidwho-1279469
ABSTRACT
Frequent clinical presentations have been reported in patients with Coronavirus disease 2019 (COVID-19). It may be associated with multi-organ and cardiovascular involvements such as myocarditis and clot formation. Hypereosinophilic syndrome (HES) is a rare disease diagnosed with idiopathic eosinophilia and organ involvement. Here, we report a patient with COVID-19 who presented with clot formation and myocarditis. One month after discharge, regarding persistent peripheral/bone marrow hypereosinophilia and clot in echocardiography, fluorescent in situ hybridization (FISH) analysis was done that showed FIP1L1-CHIC2 fusion (PDGFRÉ rearrangement) in 18% of scored cells and PDGFRß rearrangement in 12% of scored cells, which confirmed HES diagnosis. Clot formation may be a late manifestation of COVID-19 or myocarditis due to COVID-19, or the first manifestation of HES that COVID-19 might provoke in this rare syndrome.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Hypereosinophilic Syndrome
/
COVID-19
/
Myocarditis
Type of study:
Case report
/
Diagnostic study
/
Prognostic study
Topics:
Long Covid
Limits:
Humans
Language:
English
Journal:
Int J Cardiovasc Imaging
Journal subject:
Diagnostic Imaging
Year:
2021
Document Type:
Article
Affiliation country:
S10554-021-02317-w
Similar
MEDLINE
...
LILACS
LIS